Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://onco.news/index.php/journal/article/view/34 |
Resumo: | Medication adherence is vital to the success of the treatment plan, being the priority of healthcare professionals to reduce the weak links that lead to medication errors and severe damage that they can cause. Based on the European profile of patients with castrate-resistant metastatic prostate cancer, the population under oral antineoplastic therapy for this pathology at Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E) during the year 2017 was characterized. In order to respond to the specific needs of this patient group, we proposed a model of adherence consultation. It is our opinion that the promotion and monitoring of the compliance must be operationalized by professionals with specialized training and motivated for this subject. The adherence consultation model is patient centric, being essential its empowerment and motivation for the therapeutic plan. With this approach we intend to enhance the quality of care and achieve health gains. |
id |
RCAP_794c8fa416242700fdf0e27aff7131cc |
---|---|
oai_identifier_str |
oai:oai.onco.news:article/34 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care realityAdesão à terapêutica oral em doentes com cancro da próstata metastático resistente à castração (CPMRC) – Realidade do serviço de H. Dia do Centro Hospitalar Gaia/EspinhoAdesãoMotivaçãoCapacitaçãoTerapêutica oral antineoplásicaAdherenceMotivationEmpowermentOral antineoplastic therapyMedication adherence is vital to the success of the treatment plan, being the priority of healthcare professionals to reduce the weak links that lead to medication errors and severe damage that they can cause. Based on the European profile of patients with castrate-resistant metastatic prostate cancer, the population under oral antineoplastic therapy for this pathology at Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E) during the year 2017 was characterized. In order to respond to the specific needs of this patient group, we proposed a model of adherence consultation. It is our opinion that the promotion and monitoring of the compliance must be operationalized by professionals with specialized training and motivated for this subject. The adherence consultation model is patient centric, being essential its empowerment and motivation for the therapeutic plan. With this approach we intend to enhance the quality of care and achieve health gains.A adesão à terapêutica é fundamental para o sucesso do tratamento instituído, sendo uma prioridade dos profissionais de saúde reduzir os pontos fracos que levam a erros de medicação e graves danos que daí advêm. Tendo por referência o perfil europeu dos doentes com Cancro da Próstata Metastático Resistente à Castração (CPmRC), caracterizou-se a população sob terapêutica oral antineoplásica para esta patologia no Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), durante o ano de 2017. Para dar resposta às necessidades específicas deste grupo de doentes, propôs-se um modelo de consulta de adesão. É nossa opinião que a promoção da adesão e a monitorização da compliance devem ser operacionalizadas por profissionais com formação especializada e motivados para esta temática. O modelo de consulta de adesão tem como pilar central o doente, sendo fundamental a sua capacitação e motivação para o plano terapêutico. Com esta abordagem pretendemos potenciar a qualidade dos cuidados e obter ganhos em saúde.AEOP – Associação de Enfermagem Oncológica Portuguesa2019-12-20info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/34Onco.news; No. 39 (2019): Onco.News Journal (july-december); 12-16Onco.News; N.º 39 (2019): Revista Onco.News (julho-dezembro); 12-162183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/34https://onco.news/index.php/journal/article/view/34/56Direitos de Autor (c) 2019 Joana Fernandes Silva , Sandra Custódio, João Fragainfo:eu-repo/semantics/openAccessFernandes Silva , JoanaCustódio, SandraFraga, João2024-03-16T07:55:11Zoai:oai.onco.news:article/34Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:19.507124Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality Adesão à terapêutica oral em doentes com cancro da próstata metastático resistente à castração (CPMRC) – Realidade do serviço de H. Dia do Centro Hospitalar Gaia/Espinho |
title |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality |
spellingShingle |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality Fernandes Silva , Joana Adesão Motivação Capacitação Terapêutica oral antineoplásica Adherence Motivation Empowerment Oral antineoplastic therapy |
title_short |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality |
title_full |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality |
title_fullStr |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality |
title_full_unstemmed |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality |
title_sort |
Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality |
author |
Fernandes Silva , Joana |
author_facet |
Fernandes Silva , Joana Custódio, Sandra Fraga, João |
author_role |
author |
author2 |
Custódio, Sandra Fraga, João |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Fernandes Silva , Joana Custódio, Sandra Fraga, João |
dc.subject.por.fl_str_mv |
Adesão Motivação Capacitação Terapêutica oral antineoplásica Adherence Motivation Empowerment Oral antineoplastic therapy |
topic |
Adesão Motivação Capacitação Terapêutica oral antineoplásica Adherence Motivation Empowerment Oral antineoplastic therapy |
description |
Medication adherence is vital to the success of the treatment plan, being the priority of healthcare professionals to reduce the weak links that lead to medication errors and severe damage that they can cause. Based on the European profile of patients with castrate-resistant metastatic prostate cancer, the population under oral antineoplastic therapy for this pathology at Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E) during the year 2017 was characterized. In order to respond to the specific needs of this patient group, we proposed a model of adherence consultation. It is our opinion that the promotion and monitoring of the compliance must be operationalized by professionals with specialized training and motivated for this subject. The adherence consultation model is patient centric, being essential its empowerment and motivation for the therapeutic plan. With this approach we intend to enhance the quality of care and achieve health gains. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12-20 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://onco.news/index.php/journal/article/view/34 |
url |
https://onco.news/index.php/journal/article/view/34 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://onco.news/index.php/journal/article/view/34 https://onco.news/index.php/journal/article/view/34/56 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2019 Joana Fernandes Silva , Sandra Custódio, João Fraga info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2019 Joana Fernandes Silva , Sandra Custódio, João Fraga |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
AEOP – Associação de Enfermagem Oncológica Portuguesa |
publisher.none.fl_str_mv |
AEOP – Associação de Enfermagem Oncológica Portuguesa |
dc.source.none.fl_str_mv |
Onco.news; No. 39 (2019): Onco.News Journal (july-december); 12-16 Onco.News; N.º 39 (2019): Revista Onco.News (julho-dezembro); 12-16 2183-6914 1646-7868 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138187163992064 |